Pursuant to the ‘Code of Conduct for Prevention of Insider Trading’ of the Company, SEBI (Prohibition of Insider Trading) Regulations, 2015 and clarification given by BSE vide its letter ref no LIST/COMP/01/2019-20 dated April 2,2019 regarding trading restrictions period, Sandu Pharmaceuticals has informed that the trading window for dealing in Securities of the Company shall remain closed from Thursday, 01st January 2026 till 48 hours after the declaration of the financial results of the Company for the quarter ended 31st December 2025 for Directors, KMPs, Promoters And Promoters Group and Designated Persons ,Immediate Relative etc covered under the Code. The date of the Board Meeting for consideration of the Unaudited Financial Results of the Company for the quarter ended 31st December 2025 will be intimated in due course. Accordingly, all Designated Persons and their immediate relatives are advised not to trade in the securities of the Company during the aforesaid trading window closure period.
The above information is a part of company’s filings submitted to BSE.
